Edgewise Therapeutics, Inc. (EWTX) Annual Margin Report - Discounting Cash Flows
EWTX
Edgewise Therapeutics, Inc.
EWTX (NASDAQ)

Annual Margin Analysis Report

Margins refer to the ratio between a financial report item and the revenue (Example: Net Income Margin = Net Income / Revenue).

This analysis provides a report of the company's key margins, which could be further used in a valuation model.

Interactive Assumptions

Historical Years

Historical Years

Number of historical years used to render the Chart and Tables.

Margin Analysis (% of Revenue)

Monetary values in USD

Monetary values in USD

amounts except #

Average LTM
Jan 19
2024
Dec 31
2023
Dec 31
2022
Dec 31
2021
Dec 31
2020
Dec 31
Revenue
0 0 0 0 0 0
Revenue Growth Rate
Cost of Revenue 0.031 0 0 0 0 0 0.185
Gross Profit -0.031 0 0 0 0 0 -0.185
Gross Margin
Operating Income -97.7 -181 -158.8 -114.4 -71.66 -43.22 -17.19
Operating Margin
Net Income -86.45 -157.2 -133.8 -100.2 -67.64 -42.81 -17.05
Net Margin

Monetary values in USD

amounts except #

Average LTM
Jan 19
2024
Dec 31
2023
Dec 31
2022
Dec 31
2021
Dec 31
2020
Dec 31
Revenue
0 0 0 0 0 0
Cash From Operating Activities Margin
Cash From Operating Activities -72.32 -132.2 -109 -91.95 -52.63 -33.51 -14.63
Free Cash Flow Margin
Free Cash Flow -74.64 -132.6 -110.3 -97.69 -58.18 -34.17 -14.84
Depreciation and Amortization Margin
Depreciation and Amortization 1.22 2.32 2.29 1.73 0.538 0.272 0.185
Capital Expenditure Margin
Capital Expenditure -2.32 -0.457 -1.31 -5.75 -5.55 -0.668 -0.203
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program